Filing Details

Accession Number:
0001140361-16-090510
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-21 17:30:37
Reporting Period:
2016-12-19
Filing Date:
2016-12-21
Accepted Time:
2016-12-21 17:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579310 T. Keith Flaherty C/O Loxo Oncology, Inc.
281 Tresser Blvd, 9Th Floor
Stamford CT 06901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-19 7,250 $30.23 38,732 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 13, 2016.